Upside, Downside Movers in the Morning
Upside:
-WYY +45% (selected as the single awardee for 10-yr, $3.1B DHS Cellular Wireless Managed Services 3.0 IDIQ contract)
-TECH +19% (offered to be acquired by Merck KGaA at $73/shr in $11.3B cash deal)
-MU +17% (earnings, guidance)
-SNDK +15% (higher in sympathy with MU)
-WDC +12% (higher in sympathy with MU)
-KYMR +10% (completes enrollment in the Phase 2b BROADEN2 Trial of KT-621 in Atopic Dermatitis with topline data by year-end 2026)
-QCOM +10% (strength following Investor Day, guidance)
-SNX +8.4% (earnings, guidance)
-WEN +7.1% (meme momentum)
-BB +7.0% (earnings, guidance)
-UMAC +4.8% (signs lease for 14K sq ft Orlando manufacturing and operations facility)
-STM +4.0% (higher in sympathy with MU)
-MKC +3.0% (earnings, guidance)
-MDA +2.8% (selected by Mitsubishi Electric for next gen defence communications satellite program)
-IBM +2.7% (unveils sub-1 nm chip technology with 0.7 nm node and new nanostack architecture)
-VC +2.4% (authorizes $800M share repurchase program)
-SPCX +2.3% (momentum)
Downside:
-ELME -28% (terminates Purchase Agreement with Riverside Apartments)
-SPRY -25% (no new formulary additions for neffy in July 1, 2026 cycle)
-FUL -10% (earnings, guidance; Ancora criticizes H.B. Fuller pursuit of Advanced Medical Solutions acquisition)
-TSHA -5.6% (prices $200M public offering of common stock and pre-funded warrants at $6.00/share)
-WGO -3.0% (earnings, guidance)
-DLTR -2.8% (to repurchase $500M of common stock alongside secondary block trade)
-DRI -2.6% (earnings, guidance)
-PVH -2.4% (Tier1 firm Cuts PVH to Underperform from Neutral, price target: $70 from $90)
